Albert Labs International Corp. (ABRT.CN)

0.0150 0.0000 (0.00%) At close: 12:41PM EDT

Albert Labs International Corp.

201-6996 Merritt Avenue
Burnaby, BC V5J 4R6
Canada
778-819-0740
https://albertlabs.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Navchand Jagpal	Acting CEO, CFO & Director	N/A	N/A	1968
Santoke Naal	Chief Operating Officer	N/A	N/A	N/A
Mr. Toby Sorabjee	Chief Communications Officer	N/A	N/A	N/A
Dr. Malcolm Barratt-Johnson	Chief Medical Officer	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Albert Labs International Corp., a biopharmaceutical drug discovery company, researches and develops drugs for psychedelic-assisted therapy for patients with urgent and unmet needs in Canada and the United Kingdom. It develops KRN-101, is a solution for cancer-related anxiety. The company is based in Burnaby, Canada.

Corporate Governance

Albert Labs International Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.